Anbio Biotechnology Increase (Decrease) in Prepaid Expense and Other Assets
Anbio Biotechnology (NNNN) reported Increase (Decrease) in Prepaid Expense and Other Assets of $581.47 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-04-07
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|
| 2025-12-31 | $581.47K 20-F · filed 2026-04-07 |
| 2024-12-31 | -$396.27K 20-F · filed 2026-04-07 |
| 2023-12-31 | $306.00K 20-F · filed 2026-04-07 |
| 2022-12-31 | $81.02K 20-F · filed 2025-04-28 |